The RING finger protein family in health and disease

C Cai, YD Tang, J Zhai, C Zheng - Signal transduction and targeted …, 2022 - nature.com
Ubiquitination is a highly conserved and fundamental posttranslational modification (PTM) in
all eukaryotes regulating thousands of proteins. The RING (really interesting new gene) …

What did we learn from the molecular biology of adrenal cortical neoplasia? From histopathology to translational genomics

CC Juhlin, J Bertherat, TJ Giordano, GD Hammer… - Endocrine …, 2021 - Springer
Approximately one-tenth of the general population exhibit adrenal cortical nodules, and the
incidence has increased. Afflicted patients display a multifaceted symptomatology …

[HTML][HTML] Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors

K Li, H Luo, H Luo, X Zhu - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Abstract N6-methyladenosine (m6A), internal modification of mRNA, has recently been
reported to be an important regulatory mechanism affecting tumor proliferation. However, its …

The role of biomarkers in adrenocortical carcinoma: a review of current evidence and future perspectives

M Mizdrak, T Tičinović Kurir, J Božić - Biomedicines, 2021 - mdpi.com
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy arising from the adrenal
cortex often with unexpected biological behavior. It can occur at any age, with two peaks of …

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study

O Kimpel, S Bedrose, F Megerle, A Berruti… - British Journal of …, 2021 - nature.com
Background After radical resection, patients with adrenocortical carcinoma (ACC) frequently
experience recurrence and, therefore, effective adjuvant treatment is urgently needed. The …

[HTML][HTML] Current evidence on local therapies in advanced adrenocortical carcinoma

O Kimpel, U Dischinger, B Altieri… - Hormone and …, 2024 - thieme-connect.com
International guidelines emphasise the role of local therapies (LT) for the treatment of
advanced adrenocortical carcinoma (ACC). However, large studies are lacking in this field …

FNDC5 and AKR1B10 inhibit the proliferation and metastasis of adrenocortical carcinoma cells by regulating AMPK/mTOR pathway

D Chen, R Huang, F Ren, H Wang… - Experimental and …, 2023 - spandidos-publications.com
Being a rare malignancy, adrenocortical carcinoma (ACC) exhibits aggressiveness and poor
prognosis. Fibronectin type III domain‑containing protein 5 (FNDC5) is a transmembrane …

Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience

LH Pan, CC Yen, CJ Huang, XN Ng… - Frontiers in …, 2023 - frontiersin.org
Background The prognosis of adrenocortical carcinoma (ACC) is poor but highly variable.
The present study aimed to characterize patients with ACC at a single center in Taiwan and …

Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study

F Zhang, Z Liu, J Liang, S Liu, K Wu, F Zhang, C Zhou… - BMC cancer, 2021 - Springer
Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a
poor prognosis. Given the limited treatment options, prognostic assessment of ACC is …

Revisiting the AJCC staging system of adrenocortical carcinoma

O Abdel-Rahman - Journal of Endocrinological Investigation, 2022 - Springer
Objective To evaluate the performance characteristics of AJCC 7th and 8th staging systems
among patients with adrenal cortical carcinoma. Methods Surveillance, Epidemiology, and …